Pierre-Olivier Cheptou | Biological Sciences | Excellence in Innovation Award

Posted on by Shen Awards

Dr. Pierre-Olivier Cheptou | Biological Sciences | Excellence in Innovation Award

Research Director from CNRS | France

Pierre-Olivier Cheptou is a distinguished evolutionary ecologist whose research has transformed the understanding of how plants adapt to urban environments. Based at CEFE-CNRS in Montpellier, France, he specializes in evolutionary dynamics, seed dispersal, mating systems, and plant responses to anthropogenic changes. With over two decades of research experience, Cheptou has led several major projects and contributed significantly to the fields of plant ecology, population biology, and eco-evolutionary dynamics. His highly influential paper on the rapid evolution of seed dispersal in Crepis sancta published in PNAS in set the foundation for his reputation as a global expert on urban evolution. He is recognized not only for his academic contributions but also for his ability to bridge theoretical research with real-world applications. Cheptou’s work demonstrates how cities can serve as natural laboratories for studying evolution, providing new perspectives on biodiversity and ecological resilience. With an H-index of 33 and 90 international publications, he is a respected leader in the field. His affiliations with multiple scientific committees, journals, and ecological networks further validate his commitment to advancing scientific knowledge and fostering collaborative research. His dedication to mentoring and academic leadership reinforces his impact on the future of evolutionary ecology.

Professional Profile

Scopus Profile | ORCID Profile

Education

Pierre-Olivier Cheptou has a solid academic foundation rooted in evolutionary biology and ecology. He began his higher education at Montpellier University, where he earned a Master of Science (MSc) degree in Evolutionary Biology and Ecology. Driven by a keen interest in population biology and ecological adaptation, he pursued doctoral research at the same institution. He completed his Ph.D. in Population Biology and Ecology at Montpellier University, producing work that laid the groundwork for his later research on seed dispersal and mating systems in plant populations. Further solidifying his academic leadership, Dr. Cheptou obtained his Habilitation à diriger des recherches (HDR), which is a prestigious post-doctoral qualification in France that certifies the ability to supervise doctoral research. This academic progression—from MSc to Ph.D. and HDR—demonstrates a consistent focus on evolutionary mechanisms, ecology, and adaptation, especially in relation to plant species in anthropogenic and natural environments. These credentials have not only positioned him to lead groundbreaking research but also to mentor graduate and doctoral students effectively, expanding the intellectual reach of his work through teaching and supervision at major European institutions.

Experience

Dr. Pierre-Olivier Cheptou has held a series of progressive and impactful roles throughout his professional career. Following his doctoral studies, he undertook a prestigious post-doctoral stay at McGill University in Montreal, Canada, in Dan Schoen’s lab. This international experience strengthened his collaborative networks and exposed him to advanced methods in population biology and genetics. He began his career with the French National Centre for Scientific Research (CNRS) as a CR2-level researcher at CEFE (Centre d’Écologie Fonctionnelle et Évolutive). He was promoted to CR1 and then to Directeur de Recherche 2 (DR2), reflecting his growing contributions and leadership in the field. Over the years, he has coordinated multiple national and international research projects, supervised numerous graduate students, and contributed to the development of CEFE’s research infrastructure. Notably, he served as the head of the “Dynamics and Adaptation of Plant Populations” group and as the scientific coordinator of the Labex CeMEB experimental platform. He has also taught at Montpellier University and was an Associate Professor at Université Libre de Bruxelles. These roles highlight his interdisciplinary expertise and significant impact on ecological research and education in France and beyond.

Research Interest

Pierre-Olivier Cheptou’s research interests lie at the intersection of evolutionary ecology, plant population biology, and urban ecology. He explores how plants adapt to human-altered environments, with a specific focus on seed dispersal mechanisms, mating systems, and eco-evolutionary feedbacks. A central theme in his research is understanding rapid evolutionary responses to urbanization, treating cities as active evolutionary arenas rather than ecological dead ends. His pioneering work on Crepis sancta demonstrated how urban landscapes influence natural selection and trait evolution. He is deeply interested in “resurrection ecology,” where seeds preserved over time are germinated to assess evolutionary changes across generations. His projects investigate the evolutionary consequences of pollinator decline, fragmentation, and habitat alteration on plant traits. Cheptou is also involved in integrating theoretical models with empirical data, extending metapopulation models and hidden Markov models to estimate seed dormancy and dispersal. These interests converge in a multidisciplinary framework that combines ecology, genetics, statistics, and conservation biology. By linking fundamental evolutionary theory with applied conservation and urban planning, his research contributes to both scientific advancement and practical biodiversity management. His ongoing commitment to interdisciplinary and international collaboration underscores his role as a thought leader in the field of urban evolutionary biology.

Research Skills

Dr. Cheptou brings a diverse and robust research skill set to the field of evolutionary ecology. He is highly proficient in field experimentation, statistical modeling, and evolutionary analysis, particularly in urban ecological contexts. One of his unique strengths lies in his ability to bridge empirical and theoretical approaches. His use of hidden Markov models to estimate traits such as seed dormancy and dispersal demonstrates his advanced statistical competencies. Additionally, he is skilled in genetic and ecological sampling techniques, enabling him to link phenotypic changes with underlying evolutionary drivers. His work involves the application of resurrection ecology methods, which require long-term seed storage, precise phenotyping, and temporal comparisons to measure evolutionary change. Cheptou also excels in interdisciplinary research design, combining concepts from ecology, population genetics, and landscape biology. He is adept at research coordination, having led multiple collaborative projects funded by institutions such as the NSF (USA), FRB, OFB, and the French Ministry of Higher Education and Research. His editorial and peer review activities for journals like Evolution, BMC Evolutionary Biology, American Naturalist, and New Phytologist further demonstrate his critical evaluation and communication skills. These competencies allow him to produce high-quality, high-impact research that informs both academic circles and public environmental policy.

Awards and Honors

Throughout his career, Pierre-Olivier Cheptou has been recognized for his innovative and impactful research through numerous grants and honors. He was the recipient of the Young Researcher ACI program grant for his pioneering work on urban plant populations. His leadership in the FRB research program on plant adaptation through resurrection ecology further positioned him at the forefront of ecological evolution studies. He also led the “Chercheurs d’avenir” project, supported by Région Languedoc-Roussillon, focusing on advancing metapopulation models in plant biology. Internationally, he was a key participant in the Nescent Working Group funded by the NSF (USA), exploring the evolutionary limits of Baker’s law. In recent years, he has secured funding for large-scale projects, including the ongoing “Resurrection Ecology in Agrostemma githago” and “Plant Adaptation in a Rural/Urban Gradient”, funded by OFB and Région Occitanie. He has served on evaluation panels for international funding bodies such as NSF, Israel Science Foundation, ERC, and Czech Science Foundation. His editorial appointments with leading journals and invitations to speak at major international conferences reinforce his esteemed status in the academic community. These accolades reflect his consistent excellence in research, leadership, and collaboration.

Publication Top Notes

  • Non parametric observation-driven hidden Markov model, 2025.

  • Fisher’s automatic advantage of self-fertilization does not apply in cleistogamous species, 2024 — 1 citation

  • A hemizygous supergene controls homomorphic and heteromorphic self-incompatibility systems in Oleaceae, 2024 — 7 citations

  • Ongoing convergent evolution of a selfing syndrome threatens plant–pollinator interactions, 2024 — 15 citations

  • Evolution of plant mating systems in the face of global change, 2024 — 1 citation

  • The evolutionary ecology of inbreeding depression in wild plant populations and its impact on plant mating systems, 2024 — 3 citations

  • Limitation of gene flow by distance in the common yellow jasmine (Chrysojasminum fruticans, Oleaceae): implications for the study of its mating strategies, 2024 — 2 citations

  • Male fertility advantage within and between seasons in the perennial androdioecious plant Phillyrea angustifolia, 2023 — 3 citations

Conclusion

Pierre-Olivier Cheptou is a visionary researcher whose work has redefined how scientists view plant adaptation in urban settings. His influential studies on evolutionary responses in fragmented and anthropogenic habitats have significantly advanced the field of evolutionary ecology. Through cutting-edge projects, interdisciplinary collaborations, and impactful mentorship, he has shaped both scientific inquiry and policy discussions on biodiversity and adaptation. His ability to translate complex ecological concepts into actionable knowledge makes him not just a prolific academic but a valuable contributor to societal understanding of environmental resilience. With a robust publication record, international recognition, and a proven track record in research leadership, Dr. Cheptou exemplifies the kind of innovative and socially relevant science the world needs. His future trajectory promises continued contributions to evolutionary biology, urban ecology, and biodiversity conservation. He is undoubtedly a deserving candidate for recognition in international research awards celebrating excellence in science, health, and engineering.




























	


	

	






	
	

		


Fu Xiaocong | Molecular Biology | Best Innovation Award
			

				Posted on  by Shen Awards			

		
	


	

		
Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award


Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia


Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.


Professional Profile



Education


Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.


Professional Experience


Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.


Research Interests


Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.


Research Skills


Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.


Awards and Honors


Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.


Conclusion


Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.

	


	

	






	
	

		


Rui Wen | Molecular Biology | Best Researcher Award
			

				Posted on  by Shen Awards			

		
	


	

		
Assist. Prof. Dr. Rui Wen | Molecular Biology | Best Researcher Award


Assistant Professor Dr at Wenzhou Medical University, China










Rui Wen, an Assistant Professor at Wenzhou Medical University in China, has focused on advancing research in biomaterials, with a special interest in silk proteins for drug delivery systems. Since earning his PhD in Biomaterials from Donghua University in 2020, Rui has quickly established a reputable profile through his publications in high-impact journals and his role in editorial positions. His work encompasses essential biological processes like protein function, alternative splicing, and gene expression, with an emphasis on the use of silk-based materials for medical applications. Rui is actively involved in peer-reviewed publications, authoring eight first-author or corresponding-author articles in prominent journals over the past five years. Additionally, he has contributed to the scientific community by serving as an editorial board member and reviewer for multiple journals, illustrating his influence and expertise in the field of biomaterials.


Professional Profile



Education


Rui Wen completed his PhD in Biomaterials at Donghua University in 2020, where he focused on the biological functions of protein materials, especially silk-based biomaterials for drug delivery. His doctoral research established foundational insights into protein functionality and biomimetic applications, shaping his future focus on protein function and genetic analysis. Throughout his education, Rui developed a sophisticated understanding of biomaterials science, from molecular genetics to applications in medical technology. His PhD laid a robust academic and technical foundation, equipping him with the essential research methodologies and laboratory skills needed to contribute meaningfully to the biomaterials field. The strong academic training he received at Donghua University, combined with hands-on experience in research, has been instrumental in his transition to his current role as an Assistant Professor, where he continues to leverage his expertise in gene expression and protein function.


Professional Experience


Rui Wen’s professional journey as an Assistant Professor at Wenzhou Medical University began shortly after he completed his PhD. In this role, Rui has focused his research on developing silk-based biomaterials for medical applications, such as drug delivery. His work often involves collaborations with other experts in the biomaterials and genetic research fields, emphasizing protein functionality and biomimetic design. Rui’s academic contributions include publishing eight peer-reviewed papers as the first or corresponding author in recognized journals, including Acta Biomaterialia and the International Journal of Biological Macromolecules. These achievements highlight his commitment to advancing scientific knowledge in biomaterials. Additionally, Rui serves on editorial boards for journals like the World Journal of Biological Chemistry, further underscoring his dedication to scientific excellence and community engagement. His involvement in these roles signifies his professional growth and increasing impact within the scientific community.


Research Interests


Rui Wen’s research interests are centered on protein function, gene expression, and biomaterials, particularly focusing on the medical potential of silk-based proteins. He is intrigued by the genetic underpinnings of protein function and the application of alternative splicing in creating materials that mimic biological functions. His work has a dual focus: understanding protein behavior at a genetic level and leveraging this knowledge to develop innovative biomaterials for drug delivery. This focus on silk-based proteins, a biologically compatible and robust material, has led Rui to explore how protein sequences can be harnessed to design highly specialized biomaterials with practical medical applications. Rui’s research aims to integrate genetic insights with material science to produce versatile, biocompatible materials that can advance drug delivery and other medical therapies, contributing to new solutions in biotechnology and healthcare.


Research Skills


Rui Wen possesses extensive research skills in biomaterials science and protein analysis. His expertise includes characterizing protein functionality, analyzing gene sequences, and applying genetic engineering principles to create innovative materials. Rui has a strong background in protein biochemistry and molecular biology, which has enabled him to identify and engineer silk proteins for biomimetic applications. Additionally, he is skilled in alternative splicing and concerted evolution, both of which play a crucial role in his work with gene expression. Rui’s laboratory skills include various analytical techniques, such as protein characterization assays, molecular modeling, and genetic sequencing. His ability to publish consistently in peer-reviewed journals reflects his proficiency in scientific communication and data analysis. Furthermore, his role as a reviewer and editor highlights his critical assessment skills, making him a valuable contributor to the scientific community.


Awards and Honors


Rui Wen’s contributions to biomaterials science have been recognized through multiple awards and honors. He received funding from the China Postdoctoral Science Foundation, a competitive grant that supports emerging researchers in China. This funding enabled him to continue his exploration of silk-based proteins and their applications in drug delivery. His role on the editorial boards of respected journals like the World Journal of Biological Chemistry and Biomedical Engineering Communications is another notable achievement, reflecting the respect he has earned among his peers. In addition, his status as an invited reviewer for journals such as the International Journal of Biological Macromolecules demonstrates his expertise and the high regard of the scientific community. These honors underscore Rui’s dedication to advancing biomaterials science and highlight his influence in the fields of protein function and gene expression.










Conclusion


Rui Wen is a dedicated and promising researcher whose accomplishments in the specialized areas of protein function and biomaterials are commendable for someone early in their career. His expertise, consistent publication record, and increasing engagement with the scientific community through editorial and reviewing activities make him a competitive candidate for the Best Researcher Award. With further developments in his citation impact and expanded international collaborations, Rui Wen’s contributions are likely to gain even greater visibility and influence, establishing him as a key figure in biomaterials research.


Publications Top Notes










    

  1. Title: Physical Properties of the Second Type of Aciniform Spidroin (AcSp2) from Neoscona theisi Reveal a pH-Dependent Self-Assembly Repetitive Domain
    
Authors: Yang, D., Wang, S., Wang, K., Zan, X., Wen, R.
    
Journal: ACS Biomaterials Science and Engineering
    
Year: 2023
    
Volume(Issue): 9(12)
    
Pages: 6670–6682
    
Citations: 1
    2. 

  2. Title: Complete Gene Sequence and Mechanical Property of the Fourth Type of Major Ampullate Silk Protein
    
Authors: Wen, R., Wang, S., Wang, K., Zan, X., Meng, Q.
    
Journal: Acta Biomaterialia
    
Year: 2023
    
Volume: 155
    
Pages: 282–291
    
Citations: 4
    3. 

  3. Title: Characterization of Two Full-Length Tubuliform Silk Gene Sequences from Neoscona theisi Reveals Intragenic Concerted Evolution and Multiple Copies in Genome
    
Authors: Wen, R., Wang, K., Zan, X.
    
Journal: International Journal of Biological Macromolecules
    
Year: 2022
    
Volume: 223
    
Pages: 1015–1023
    
Citations: 3
    4. 

  4. Title: Characterization of Two Full-Length Araneus ventricosus Major Ampullate Silk Protein Genes
    
Authors: Wen, R., Yang, D., Wang, K., Zan, X.
    
Journal: International Journal of Biological Macromolecules
    
Year: 2022
    
Volume: 213
    
Pages: 297–304
    5. 

  5. Title: The Novel Aciniform Silk Protein (AcSp2-v2) Reveals the Unique Repetitive Domain with High Acid and Thermal Stability and Self-Assembly Capability
    
Authors: Wen, R., Wang, K., Yang, D., Zan, X., Meng, Q.
    
Journal: International Journal of Biological Macromolecules
    
Year: 2022
    
Volume: 202
    
Pages: 91–101
    
Citations: 6
    6. 

  6. Title: Customized Flagelliform Spidroins Form Spider Silk-Like Fibers at pH 8.0 with Outstanding Tensile Strength
    
Authors: Li, X., Qi, X., Cai, Y.-M., Meng, Q., Chen, G.
    
Journal: ACS Biomaterials Science and Engineering
    
Year: 2022
    
Volume(Issue): 8(1)
    
Pages: 119–127
    
Citations: 14
    7. 

  7. Title: Characterization of the Second Type of Aciniform Spidroin (AcSp2) Provides New Insight into Design for Spidroin-Based Biomaterials
    
Authors: Wen, R., Wang, K., Meng, Q.
    
Journal: Acta Biomaterialia
    
Year: 2020
    
Volume: 115
    
Pages: 210–219
    
Citations: 16
    8. 

  8. Title: Two Novel Tubuliform Silk Gene Sequences from Araneus ventricosus Provide Evidence for Multiple Loci in Genome
    
Authors: Wen, R., Wang, K., Meng, Q.
    
Journal: International Journal of Biological Macromolecules
    
Year: 2020
    
Volume: 160
    
Pages: 806–813
    
Citations: 10
    9. 

  9. Title: Wet-Spinning Synthetic Fibers from Aggregate Glue: Aggregate Spidroin 1 (AgSp1)
    
Authors: Li, X., Mi, J., Wen, R., Meng, Q., Lin, Y.
    
Journal: ACS Applied Bio Materials
    
Year: 2020
    
Volume(Issue): 3(9)
    
Pages: 5957–5965
    
Citations: 10
    10. 

  10. Title: Novel Highly Soluble Chimeric Recombinant Spidroins with High Yield
    
Authors: Jia, Q., Wen, R., Meng, Q.
    
Journal: International Journal of Molecular Sciences
    
Year: 2020
    
Volume(Issue): 21(18)
    
Pages: 1–13, Article ID: 6905
    
Citations: 11
    11. 
































































	


	

	






	
	

		


Jaafar Abduo | Prosthodontics | Best Researcher Award
			

				Posted on  by Shen Awards			

		
	


	

		
Assoc Prof Dr. Jaafar Abduo | Prosthodontics | Best Researcher Award


Prosthodontist at Melbourne Dental School, Australia.










































Dr. Jaafar Abduo is an Associate Professor of Prosthodontics at Melbourne Dental School, University of Melbourne. He holds a PhD from the University of Western Australia and has extensive experience in clinical dentistry. His research focuses on digital workflows, implant prosthodontics, and the evaluation of modern dental manufacturing techniques. Dr. Abduo has published over 90 peer-reviewed papers and has a significant impact on the field, with an h-index of 30 and more than 4,600 citations. He collaborates with leading dental companies and has been awarded multiple national and international grants. Additionally, he serves on various academic and professional committees, contributing to research ethics, curriculum development, and continuing education. Dr. Abduo’s work has been presented at major international conferences, and his innovations have influenced both academic research and clinical practices in prosthodontics globally.






























Profile















Education




















































Dr. Jaafar Abduo’s educational background is distinguished by his extensive training in dentistry and prosthodontics. He earned his Doctor of Philosophy (PhD) by publication from the University of Western Australia in 2016, which reflects his significant contributions to dental research. Prior to this, he completed the Doctor of Clinical Dentistry in Prosthodontics (DClinDent) at the University of Otago, Dunedin, New Zealand, in 2010, underscoring his specialized expertise in prosthodontics. His journey began with a Bachelor of Dental Surgery with credit from the University of Otago in 2004. Additionally, he achieved Membership of the Royal Australasian College of Dental Surgeons in Prosthodontics (MRACDS Pros) through examination in Sydney, Australia, in 2011. This robust educational foundation has equipped Dr. Abduo with the knowledge and skills necessary to advance the field of dental prosthetics.




























Professional Experience






















































































Dr. Jaafar Abduo is an accomplished prosthodontist and Associate Professor at the Melbourne Dental School, University of Melbourne. Since January 2020, he has held the position of Associate Professor (Level D) in Prosthodontics, where he also serves as the Convenor for the Doctor of Clinical Dentistry (Prosthodontics) program and the Postgraduate Diploma in Clinical Dentistry (Implants). Dr. Abduo’s career at the Melbourne Dental School began in 2013 as a Senior Lecturer (Level C) in Prosthodontics. Alongside his academic roles, he has been a practicing specialist prosthodontist in private practice since 2011. Dr. Abduo’s expertise spans removable prosthodontics, complex rehabilitation, and implant prosthodontics, and he is actively involved in both teaching and research. His work is well-regarded, with numerous peer-reviewed publications and significant contributions to advancing dental education and clinical practice.


























Research Interest




























































Dr. Jaafar Abduo’s research interests are centered around advancing prosthodontics, with a particular focus on digital dentistry and modern manufacturing techniques. He explores the development and evaluation of digital workflows for diagnostics, conventional, removable, and implant prosthodontics, aiming to improve accuracy and efficiency in dental treatments. His work also includes randomized controlled trials to assess the clinical outcomes of materials such as monolithic zirconia and metal-ceramic implant crowns. Additionally, Dr. Abduo is interested in optimizing digital scanning methods for natural teeth, soft tissue, and implants. His biomechanical studies on implant and natural tooth comparisons, along with his research on the durability of dental prosthetics, contribute to enhancing the quality and longevity of dental restorations. Through his research, Dr. Abduo seeks to bridge the gap between clinical practice and technological advancements, ultimately improving patient outcomes in prosthodontics.










































Research Skills




















































Dr. Jaafar Abduo possesses a comprehensive set of research skills that have greatly contributed to the field of prosthodontics. His expertise lies in digital dentistry, particularly in developing and optimizing digital workflows for various prosthodontic procedures, including implant and removable prosthodontics. He is proficient in conducting randomized controlled trials and biomechanical evaluations, ensuring the clinical efficacy and durability of dental materials and techniques. Dr. Abduo’s collaboration with industry leaders showcases his ability to bridge academic research with practical applications, enhancing dental treatment outcomes. His supervisory experience, guiding numerous Doctor of Clinical Dentistry and postgraduate students, demonstrates his mentorship skills and commitment to advancing dental education. Additionally, Dr. Abduo has secured multiple research grants, highlighting his capability in securing funding and managing large-scale projects. His strong publication record, with a high h-index and numerous citations, underscores his ability to disseminate research findings effectively and contribute to the broader scientific community.












































Awards and Recognition


Dr. Abduo has received several prestigious awards and grants, including the F. A. Kernott Early Career Researcher Award and various grants from the Australian Dental Research Foundation and international sources. His high h-index and citation count further demonstrate his impact and recognition in the field.


Conclusion


Dr. Jaafar Abduo is a highly deserving candidate for the Research for Best Researcher Award. His extensive research contributions, collaborative efforts, and impactful projects in prosthodontics reflect his dedication to advancing dental science. His work has both national and international significance, making him a prominent figure in the field of dental research.










Publications Top Notes


    

  • “Muscle and joint mechanics during maximum force biting following total temporomandibular joint replacement surgery”

      

    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
      • 

    • Year: 2024
      • 

    • Citations: 0
      • 

    

    • 

  • “Effect of prefabricated immediate interim prosthesis design and insertion workflow on seating accuracy on implants placed via static computer-assisted implant surgery: A cross-sectional in vitro study”

      

    • Authors: Abduo, J., Lau, D.
      • 

    • Year: 2024
      • 

    • Citations: 0
      • 

    

    • 

  • “Influence of Implant Adjacent Teeth on the Accuracy of Digital Impression”

      

    • Authors: Abduo, J., El-Haddad, H.
      • 

    • Year: 2024
      • 

    • Citations: 0
      • 

    

    • 

  • “Seating accuracy of removable partial denture frameworks fabricated by different digital workflows in comparison to conventional workflow”

      

    • Authors: Korkes, A., Jomaa, J., Kavouris, A., Law, K.H.J., Abduo, J.
      • 

    • Year: 2024
      • 

    • Citations: 0
      • 

    

    • 

  • “Effect of pilot-guided implant placement concept on the accuracy of osteotomy preparation and implant placement”

      

    • Authors: Sharma, S., Tan, E., Tran, B., Teo, J., Abduo, J.
      • 

    • Year: 2024
      • 

    • Citations: 0
      • 

    

    • 

  • “The Effect of Various Lasers on the Bond Strength Between Orthodontic Brackets and Dental Ceramics: A Systematic Review and Meta-Analysis”

      

    • Authors: Mosaddad, S.A., Abduo, J., Zakizade, M., Tebyaniyan, H., Hussain, A.
      • 

    • Year: 2024
      • 

    • Citations: 2
      • 

    

    • 

  • “Accuracy of Static Computer-Assisted Implant Placement in Posterior Edentulous Areas with Different Levels of Tooth-Support by Novice Clinicians”

      

    • Authors: Abduo, J., Lau, D.
      • 

    • Year: 2023
      • 

    • Citations: 0
      • 

    

    • 

  • “Kinematics of the jaw following total temporomandibular joint replacement surgery”

      

    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
      • 

    • Year: 2023
      • 

    • Citations: 3
      • 

    

    • 

  • “Marginal Accuracy of Monolithic and Veneered Zirconia Crowns Fabricated by Conventional and Digital Workflows”

      

    • Authors: Abduo, J., Ho, G., Centorame, A., Le, P., Ngo, C.
      • 

    • Year: 2023
      • 

    • Citations: 3
      • 

    

    • 

  • “Measuring tooth movement with treatment using the Dahl principle: An observational study”

      

    • Authors: Bhai, K., Judge, R., Abduo, J., Palamara, J.
      • 

    • Year: 2023
      • 

    • Citations: 1
      • 

    

    • 




































	


	

	






	
	

		


Mariela Gironacci | Molecular Biology | Best Researcher Award
			

				Posted on  by Shen Awards			

		
	


	

		
Prof. Mariela Gironacci | Molecular Biology | Best Researcher Award


Professor at University of Buenos Aires , Argentina.










































Dr. Mariela Mercedes Gironacci is a distinguished Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University. With a Ph.D. from the University of Buenos Aires and a career spanning over two decades, Dr. Gironacci has made significant contributions to hypertension research. Her work focuses on the Mas receptor and its role in anti-inflammatory and antihypertensive responses. She has led multiple research projects funded by CONICET and other national and international bodies. Dr. Gironacci has received numerous awards, including the Braun Menéndez Award and the Prof. Dr. Luis Moledo Award, recognizing her excellence in hypertension research. She is an active member of professional societies, serves on editorial boards, and has delivered invited lectures globally. Her research impact is evident in her extensive publications and her leadership in advancing our understanding of the renin-angiotensin system.




























Profile















Education




















































Dr. Mariela Mercedes Gironacci holds a distinguished educational background in the field of pharmacology and biochemistry. She earned her Bachelor’s degree in Pharmacy from the National University of Córdoba, Argentina, in 1988. Building upon this foundation, she pursued advanced studies at the University of Buenos Aires, where she completed her Ph.D. in 1999. Her doctoral research contributed significantly to the understanding of the renin-angiotensin system, particularly in relation to hypertension. Dr. Gironacci’s academic journey reflects a strong commitment to advancing knowledge in her field, laying the groundwork for her subsequent research and professional achievements. Her education has equipped her with the expertise necessary to make substantial contributions to pharmacology and biochemistry, particularly in hypertension and cardiovascular research.




























Professional Experience






















































































Dr. Mariela Mercedes Gironacci is an esteemed Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University, where she has served since March 2023. Her academic career began as an Instructor in 1991, progressing to Assistant Professor (1996-2008) and then Associate Professor (2008-2023) before her current role. Concurrently, Dr. Gironacci has been a Principal Investigator at the National Council of Scientific and Technical Research (CONICET) since December 2019. Her research focuses on hypertension and cardiovascular health, particularly the Mas receptor’s role in antihypertensive responses. Her leadership extends to serving on various editorial boards, including Hypertension and the Journal of the Argentinian Society of Hypertension, and she has held significant positions in professional societies, including the Inter-American Society of Hypertension. Her extensive experience in teaching, research, and leadership underscores her significant contributions to the field.




















Research Interest




























































Dr. Mariela Mercedes Gironacci’s research primarily focuses on the role of the renin-angiotensin system (RAS) in cardiovascular health, particularly through the study of angiotensin-(1-7) and its associated Mas receptor. Her work delves into the antihypertensive and cardioprotective properties of angiotensin-(1-7), exploring its interactions with other receptors and its impact on conditions such as hypertension and Alzheimer’s disease. Dr. Gironacci’s research also examines the receptor’s involvement in inflammatory responses and its potential therapeutic targets for hypertension and neurodegenerative disorders. She is engaged in elucidating the mechanisms behind Mas receptor trafficking and its role in regulating blood pressure and cardiac function. Her contributions extend to investigating the biological responses triggered by receptor interactions, aiming to advance the understanding and treatment of hypertension and related cardiovascular diseases.










































Research Skills












































Dr. Mariela Mercedes Gironacci demonstrates exceptional research skills through her extensive work on the Mas receptor and its role in cardiovascular health. Her expertise encompasses a deep understanding of receptor regulation and trafficking, particularly in relation to antihypertensive responses. Dr. Gironacci has led pioneering studies on the depressor axis of the renin-angiotensin system, focusing on the receptor Mas and its interactions with other receptors. Her ability to design and execute complex research projects is evident in her numerous high-impact publications and successful grant applications. She employs advanced methodologies including receptor heteromerization studies, FRET approaches, and molecular modeling to unravel the mechanisms underlying hypertension and cardiovascular diseases. Additionally, her role as an editor and reviewer for leading journals underscores her commitment to maintaining rigorous research standards and advancing the field of cardiovascular pharmacology.












Awards and Recognition






















Dr. Gironacci has received numerous awards for her contributions to hypertension research, including prestigious recognitions such as the Braun Menendez Award, the Luis Moledo Award, and the Prof. Dr. C. Taquini Award. These accolades reflect her excellence in research and her impact on the field. Her recognition extends to both national and international levels, highlighting her standing as a leading researcher in her field.


Conclusion


Dr. Mariela Mercedes Gironacci’s extensive research contributions, impactful projects, and numerous awards position her as a strong candidate for the Best Researcher Award. Her work has advanced scientific understanding of hypertension and related conditions, with significant implications for both clinical practice and public health. Her dedication to research, collaborative efforts, and recognition by prestigious institutions underscore her outstanding achievements in the field.




Publications Top Notes










    

  1. Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension

      

    • Authors: J. Minetto, M.B. Cuello, F.P. Dominici, W.G. Espeche, M.M. Gironacci
      • 

    • Year: 2024
      • 

    

    2. 

  2. Unraveling the crosstalk between renin-angiotensin system receptors

      

    • Authors: M.M. Gironacci, E. Bruna-Haupt
      • 

    • Year: 2024
      • 

    

    3. 

  3. Valproate decreases transgenerationally blood pressure by affecting thyrotropin-releasing hormone promoter DNA methylation and gene expression in spontaneously hypertensive rat

      

    • Authors: M.S. Landa, M.L. Schuman, M. Aisicovich, S.I. García, C.J. Pirola
      • 

    • Year: 2024
      • 

    • 

    

    4. 

  4. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli

      

    • Authors: C. Berdasco, A. Pinto, M.G. Blake, J. Gironacci, J. Goldstein
      • 

    • Year: 2023
      • 

    • Citations: 1
      • 

    

    5. 

  5. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels

      

    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, M. Nuñez, M.M. Gironacci
      • 

    • Year: 2023
      • 

    • Citations: 12
      • 

    

    6. 

  6. Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D

      

    • Authors: M.G. Silva, F. Inserra, J. Mariani, W. Manucha, M.M. Gironacci
      • 

    • Year: 2023
      • 

    • Citations: 1
      • 

    

    7. 

  7. Mas receptor endocytosis and signaling in health and disease

      

    • Authors: N.L. Rukavina Mikusic, M.M. Gironacci
      • 

    • Year: 2023
      • 

    

    8. 

  8. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19

      

    • Authors: M.G. Silva, G.R. Corradi, J.I. Pérez Duhalde, W.G. Espeche, M.M. Gironacci
      • 

    • Year: 2022
      • 

    • Citations: 6
      • 

    

    9. 

  9. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes

      

    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, G.R. Guman, M.M. Gironacci
      • 

    • Year: 2022
      • 

    • Citations: 4
      • 

    

    10. 

  10. ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors

      

    • Authors: A.E. Portales, E.R. Mustafá, C.I. McCarthy, M. Perelló, J. Raingo
      • 

    • Year: 2022
      • 

    • Citations: 8
      • 

    

    11. 







 











































	


	

	






	
	

		


Giuseppina Caggiano | Molecular Biology | Best Researcher Award
			

				Posted on  by Shen Awards			

		
	


	

		
Prof. Giuseppina Caggiano | Molecular Biology | Best Researcher Award


Interdisciplinary Department of Medicine at University of Bari Aldo Moro, Italy.






















































































































































































































































































































































































































































































































































































































































































































































































Prof. Giuseppina Caggiano is an accomplished academic with expertise in public health, microbiology, and education. Holding positions at the University of Bari Aldo Moro, she contributes significantly to research, teaching, and leadership. Her research focuses on epidemiology, infectious diseases, environmental hygiene, and health education. Prof. Caggiano possesses a diverse set of research skills, including experimental design, data analysis, and publication. Recognized for her contributions, she has received awards and honors in her field. Overall, her dedication to advancing knowledge and improving public health outcomes underscores her impactful work in academia and healthcare.






















































































































































































































































































































































































































































































































































































































































































































































































Professional Profiles:



Education


















































Prof. Giuseppina Caggiano graduated in Biological Sciences from the University of Bari “Aldo Moro” with a grade of 105/110. She further pursued her academic journey by completing a Doctorate in Epidemiology and prevention in patients at high risk of infection from the School of Medicine at the same university. Following her doctoral studies, she specialized in Microbiology and Virology, also from the School of Medicine at the University of Bari “Aldo Moro”, achieving a remarkable score of 50/50 with honors.


Professional Experience


























Prof. Giuseppina Caggiano is currently an Associate Professor of General and Applied Hygiene (MED/42) at the University of Bari Aldo Moro. In addition to her academic role, she serves as a Biologist Manager at the Laboratory of Environmental and Food Hygiene within the Bari Policlinico Hospital-University Consortium. With expertise in microbiological monitoring of high-risk environments, she contributes significantly to infection control efforts. Prof. Caggiano also holds the position of Laboratory Director for Environmental and Food Hygiene at the University of Bari Aldo Moro and serves as the Director of the Interdepartmental Research Center for Analysis and Management of Risk in Health Emergencies (C.I.R.S.A.). Her professional journey encompasses extensive research in epidemiology, bacterial and fungal infectious diseases, environmental and food hygiene, and health education. Committed to education, she delivers lectures and courses across various health science disciplines. Prof. Caggiano’s leadership extends to coordinating educational and scientific initiatives aimed at promoting health and preventing infectious risks in healthcare settings. Through her diverse roles, she embodies a dedication to advancing public health and community well-being.



































Prof. Giuseppina Caggiano’s research interests lie at the intersection of public health and microbiology. She focuses on epidemiology and prevention of infectious diseases, particularly those caused by bacteria and fungi. Additionally, she investigates environmental hygiene and food safety, aiming to understand disease transmission dynamics and develop effective control strategies. Prof. Caggiano also explores health education and promotion initiatives to enhance public health literacy and encourage healthy behaviors. Through her interdisciplinary approach, she seeks to contribute to advancements in disease prevention and overall community well-being.


Award and Honors


























Prof. Giuseppina Caggiano has received several awards and honors in recognition of her contributions to the fields of public health, microbiology, and education. These accolades acknowledge her exceptional research, teaching, and leadership within academia and healthcare. Notable awards may include recognition for outstanding contributions to research, excellence in teaching, leadership in professional organizations, and significant impact on public health practice. Additionally, Prof. Caggiano may have received grants, fellowships, or other forms of recognition for her research endeavors. Overall, these awards and honors highlight her dedication and achievements in advancing knowledge and improving health outcomes in her respective fields.


Research Skills


























Prof. Giuseppina Caggiano possesses a comprehensive set of research skills developed through her extensive academic and professional background. She excels in experimental design, data collection, statistical analysis, and literature review. Proficient in publishing research findings and writing grant proposals, she demonstrates strong collaboration abilities and adheres to ethical standards in research conduct. With expertise spanning epidemiology, microbiology, and public health, Prof. Caggiano is adept at addressing complex research questions and contributing to advancements in knowledge and practice.


Publication


    

  1. The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021

      

    • Authors: Barchitta, M.; Maugeri, A.; Favara, G.; Galante, I.; Vinci, V.M.
      • 

    • Year: 2023
      • 

    

    2. 

  2. Consumption of Energy Drinks among Italian University students: a cross-sectional multicenter study

      

    • Authors: Protano, C.; Valeriani, F.; De Giorgi, A.; Vitali, M.; Gallè, F.
      • 

    • Year: 2023
      • 

    

    3. 

  3. Preliminary Investigation on Hygienic-Sanitary Quality of Food Vending Machines

      

    • Authors: Caggiano, G.; Marcotrigiano, V.; D’Ambrosio, M.; Sorrenti, G.T.; Montagna, M.T.
      • 

    • Year: 2023
      • 

    

    4. 

  4. Assessment of dietary supplement consumption among Italian university students: The multicenter DiSCo study

      

    • Authors: Gallè, F.; Valeriani, F.; De Giorgi, A.; Vitali, M.; Protano, C.
      • 

    • Year: 2023
      • 

    

    5. 

  5. SARS-CoV-2 RNA viability on high-touch surfaces and evaluation of a continuous-flow ozonation treatment | Vitalità di SARS-CoV-2 RNA su superfici sottoposte a frequenti contatti e valutazione di un trattamento di ozonizzazione a flusso continuo

      

    • Authors: Diella, G.; Caggiano, G.; Apollonio, F.; Galante, D.; Montagna, M.T.
      • 

    • Year: 2023
      • 

    

    6. 

  6. Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?

      

    • Authors: Caggiano, G.; Apollonio, F.; Consiglio, M.; Mosca, A.; Montagna, M.T.
      • 

    • Year: 2022
      • 

    

    7. 

  7. Investigations on the Efficacy of Ozone as an Environmental Sanitizer in Large Supermarkets

      

    • Authors: Caggiano, G.; Lopuzzo, M.; Spagnuolo, V.; Napoli, C.; Montagna, M.T.
      • 

    • Year: 2022
      • 

    

    8. 

  8. No-Touch Automated Disinfection System Based on Hydrogen Peroxide and Ethyl Alcohol Aerosols for Use in Healthcare Environments

      

    • Authors: Triggiano, F.; Caggiano, G.; Lopuzzo, M.; Fasano, F.; Montagna, M.T.
      • 

    • Year: 2022
      • 

    

    9. 

  9. How do Vaccinators Experience the Pandemic? Lifestyle Behaviors in a Sample of Italian Public Health Workers during the COVID-19 Era

      

    • Authors: Gallè, F.; Quaranta, A.; Napoli, C.; Liguori, G.; Montagna, M.T.
      • 

    • Year: 2022
      • 

    

    10. 

  10. An Artefactual Cluster of Mycobacterium abscessus Pneumonia among Cancer Patients Arising from Contamination

      

    • Authors: Diella, G.; Caggiano, G.; Triggiano, F.; Milella, P.; Montagna, M.T.
      • 

    • Year: 2022
      • 

    

    11. 




















































































































































































	


	

	






	
	

		


SUDHANSHU K BHARTI | Molecular Biology | Best Researcher Award
			

				Posted on  by Shen Awards			

		
	


	

		
Dr. SUDHANSHU K BHARTI | Molecular Biology | Best Researcher Award


Lecturer, Patna University, India


























Dr. Sudhanshu K Bharti, a distinguished lecturer at Patna University, India, has been honored with the prestigious Best Researcher Award in Molecular Biology. 🏆 His exemplary dedication and groundbreaking contributions in the field have garnered widespread recognition. Dr. Bharti’s research prowess extends to various facets of molecular biology, where his innovative work has significantly advanced scientific knowledge and understanding. With a passion for unraveling the complexities of biological systems, he continues to inspire peers and students alike, fostering a culture of excellence in research. Dr. Bharti’s achievements exemplify the pinnacle of scientific inquiry and serve as a beacon for aspiring researchers worldwide.


Profile



Education:


Sudhanshu Kumar Bharti attained a Doctorate of Philosophy (Ph.D.) in Biochemistry from Patna University in July 2014, under the guidance of Dr. Ashok Kumar Gupta. Earlier, he completed his Master of Science (M.Sc.) in Biotechnology from Allahabad Agricultural Institute Deemed University in 2006.


Employment Experience 💼


Bharti has a rich and diverse employment history. He served as an Ex-Faculty at Unacademy, mentoring students for IIT-JAM/GATE exams. He also held positions as a visiting faculty at UGC Centre for Biotechnology and PG Dept. of Biochemistry at Patna University. His roles ranged from research fellowships to course coordination, showcasing his versatility in academia.


Research Interests 🔬


Bharti’s research interests span various fields such as diabetes mellitus, phytotherapy, and biotechnology applications in agriculture. His work delves into the development of herbal formulations for combating diabetes and investigating the antidiabetic properties of bioactive compounds.


Awards and Achievements 🏆


Bharti’s accolades include CSIR-NET certifications, recognition as a mentor for top-ranking students, and contributions to academia through publications and seminars. His dedication to research and education has garnered him respect and recognition in the scientific community.


Publications Top Notes 📚


“Antidiabetic effectiveness of Phyllanthus niruri bioactive compounds via targeting DPP-IV”, 2024,


“Study on developmental biochemical characteristics of Leishmania donovani promastigote and inhibitory effect of Achyranthes aspera Linn plant extract on it”, 2022,